CUSIP 218352102COMCORTQ4 2025
38 filings · latest Feb 12, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 12.06M | $419.76M |
| 2 | Vanguard Group Inc | 9.49M | $330.42M |
| 3 | Renaissance Technologies LLC | 5.76M | $200.40M |
| 4 | Parallel Advisors, LLC | 3.88M | $134.99M |
| 5 | State Street Corp | 2.99M | $103.91M |
| 6 | Geode Capital Management, LLC | 2.67M | $92.89M |
| 7 | Fmr LLC | 2.41M | $84.03M |
| 8 | Dimensional Fund Advisors LP | 1.62M | $56.58M |
| 9 |
| 4 | Feb 21, 2025 | Ingalls &Amp; Snyder LLC | 13G/A | 7.8% | 8.17M | SEC |
| 5 | Feb 14, 2025 | Joseph K. Belanoff | 13G/A | 6.3% | — | SEC |
| 6 | Mar 27, 2024 | Ingalls & Snyder LLC | 13G/A | 8.0% | 8.26M | SEC |
| 7 | Feb 14, 2024 | Baker G Leonard Jr | 13G/A | 5.3% | 5.51M | SEC |
| 8 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 9.3% | 9.54M | SEC |
| 9 | Feb 13, 2024 | Renaissance Technologies LLC | 13G/A | 6.5% | 6.73M | SEC |
| 10 | Feb 12, 2024 | Belanoff Joseph K | 13G/A | 6.1% | 6.58M | SEC |
See the full Schedule 13D/13G history for Corcept Therapeutics Inc.
Unlock full history| 1.59M |
| $55.40M |
| 10 | Charles Schwab Investment Management Inc | 1.06M | $36.96M |